MedTech Business - April 19, 2022
GPX Medical is planning a name change
GPX Medical AB has suggested a name change in order to better gain an international position within the medtech industry and to clarify the board’s strategic focus on developing products for premature babies and neonatal intensive care. “The new name is proposed before the annual general meeting to become NEOLA Medical AB. This is important […]
Agreement - June 22, 2021
GPX Medical sells its first NEOLA system
The company has Sold its First NEOLA System to Tyndall National Institute at University College Cork to be used for a large study on newborn infants within the Irish Centre for Maternal and Child Health Research in Ireland. Tyndall National Institute at University College Cork in Ireland (UCC) will aquire a NEOLA system from GPX […]
Agreement - February 24, 2021
GPX Medical signs agreement with BTC Health Australia
The agreement gives BTC Health, through its investment company BioImpact Pty Ltd, exclusive rights to distribute NEOLA within Australia, New Zealand, Singapore and select countries in the Pacific, as soon as the regulatory process is in place. BTC Health (BTC) is an Australian company listed on the Australian Stock Exchange (ticker: BTC). The company has […]
Business article - February 1, 2021
Hey there: Hanna Sjöström, CEO, GPX Medical
GPX Medical is building on a historic Swedish legacy of medical technology innovation and the company’s mission is to revolutionize the care of infants born preterm. GPX Medical was founded in Lund, Sweden, in 2016 and is developing NEOLA, a lung analyzer for continuous monitoring of the lungs of preterm-born infants using a technology that […]
